ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy
Running, not enrolling · Phase 3
Conditions studied: Head and Neck Cancer
In brief
A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929 vs Physician's Choice Standard of Care for the Treatment of Locoregional, Recurrent Head and Neck Squamous Cell Carcinoma in Patients Who Have Failed or Progressed On or After at Least Two Lines of Therapy
Key facts
- Study ID
- NCT03769506
- Run by
- Rakuten Medical, Inc.
- People needed
- 135
- Starts
- 2019-05-09
- Expected to finish
- 2025-12-01
- Last updated by the study team
- 2025-01-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cancer Clinic — Miami, Florida, United States
- Cancer Clinic — Tampa, Florida, United States
- Cancer Clinic — Atlanta, Georgia, United States
- Cancer Clinic — Lexington, Kentucky, United States
- Cancer Clinic 1 — Philadelphia, Pennsylvania, United States
- Cancer Clinic 2 — Philadelphia, Pennsylvania, United States
- Cancer Clinic — Houston, Texas, United States
- Cancer Clinic — Vadodara, Gujarat, India
- Cancer Clinic — Vadodara, Gujarat, India
- Cancer Clinic — Bangalore, Kamataka, India
- Cancer Clinic — Kochi, Kerala, India
- Cancer Clinic — Chennai, Tamil Nadu, India
- Cancer Clinic — Hyderabad, Telangana, India
- Cancer Clinic — Kolkata, West Bengal, India
- Cancer Clinic — Mumbai, India
- Cancer Clinic — Nagoya, Aichi-ken, Japan
- Cancer Clinic — Sapporo, Hokkaido, Japan
- Cancer Clinic — Okayama, Okayama-ken, Japan
- Cancer Clinic — Chuo-ku, Tokyo, Japan
- Cancer Clinic — Taichung, Taiwan
- Cancer Clinic — Taipei, Taiwan
- Cancer Clinic — Taoyuan, Taiwan
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.